Response: Unrelated donor transplantation for adults with Ph(−) ALL in first complete remission

Autor Marks, David I., Weisdorf, Daniel J., Zhang, Mei-Jie
Vydáno 2008

Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL

Autor Abid, Muhammad Bilal, Wadhera, Karan, Bird, Jenny M., Pawade, Joya, Marks, David I.
Vydáno v Leuk Res Rep (2017)

Burden of hospitalization in acute lymphoblastic leukemia patients treated with Inotuzumab Ozogamicin versus standard chemotherapy treatment

Autor Marks, David I., van Oostrum, Ilse, Mueller, Sabrina, Welch, Verna, Vandendries, Erik, Loberiza, Fausto R., Böhme, Sarah, Su, Yun, Stelljes, Matthias, Kantarjian, Hagop M.
Vydáno v Cancer Med (2019)

Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)

Autor Rice, Claire M, Marks, David I, Walsh, Peter, Kane, Nick M, Guttridge, Martin G, Redondo, Juliana, Sarkar, Pamela, Owen, Denise, Wilkins, Alastair, Scolding, Neil J
Vydáno v BMJ Open (2015)

A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease

Autor Kebriaei, Partow, Hayes, Jack, Daly, Andrew, Uberti, Joseph, Marks, David I., Soiffer, Robert, Waller, Edmund K., Burke, Elizabeth, Skerrett, Donna, Shpall, Elizabeth, Martin, Paul J.
Vydáno v Biol Blood Marrow Transplant (2019)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation

Autor Marks, David I, Pagliuca, Antonio, Kibbler, Christopher C, Glasmacher, Axel, Heussel, Claus-Peter, Kantecki, Michal, Miller, Paul JS, Ribaud, Patricia, Schlamm, Haran T, Solano, Carlos, Cook, Gordon
Vydáno 2011

Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

Autor Redondo, Juliana, Sarkar, Pamela, Kemp, Kevin, Virgo, Paul F, Pawade, Joya, Norton, Aimie, Emery, David C, Guttridge, Martin G, Marks, David I, Wilkins, Alastair, Scolding, Neil J, Rice, Claire M
Vydáno v Mult Scler (2017)

Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden

Autor DeAngelo, Daniel J., Advani, Anjali S., Marks, David I., Stelljes, Matthias, Liedtke, Michaela, Stock, Wendy, Gökbuget, Nicola, Jabbour, Elias, Merchant, Akil, Wang, Tao, Vandendries, Erik, Neuhof, Alexander, Kantarjian, Hagop, O’Brien, Susan
Vydáno v Blood Cancer J (2020)

Outcomes In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC UKALL XII/ECOG2993 Trial

Autor Sive, Jonathan I., Buck, Georgina, Fielding, Adele, Lazarus, Hillard M., Litzow, Mark R., Luger, Selina, Marks, David I., McMillan, Andrew, Moorman, Anthony V., Richards, Susan M., Rowe, Jacob M., Tallman, Martin S., Goldstone, Anthony H.
Vydáno 2012

Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant reci...

Autor Bow, Eric J, Vanness, David J, Slavin, Monica, Cordonnier, Catherine, Cornely, Oliver A, Marks, David I, Pagliuca, Antonio, Solano, Carlos, Cragin, Lael, Shaul, Alissa J, Sorensen, Sonja, Chambers, Richard, Kantecki, Michal, Weinstein, David, Schlamm, Haran
Vydáno v BMC Infect Dis (2015)

Risk Factors and Impact of non-Aspergillus mold infections (NAMI) following Allogeneic HCT: A CIBMTR Infection & Immune Reconstitution analysis

Autor Riches, Marcie L., Trifilio, Steven, Chen, Min, Ahn, Kwang Woo, Langston, Amelia, Lazarus, Hillard M., Marks, David I., Martino, Rodrigo, Maziarz, Richard T., Papinicolou, Genofeva A., Wingard, John R., Young, Jo-Anne H., Bennett, Charles L.
Vydáno v Bone Marrow Transplant (2015)

THE EFFECT OF SMOKING ON ALLOGENEIC TRANSPLANT OUTCOMES

Autor Marks, David I., Ballen, Karen, Logan, Brent R, Wang, Zhiwei, Sobocinski, Kathleen A., Bacigalupo, Andrea, Burns, Linda J., Gupta, Vikas, Ho, Vincent, McCarthy, Philip L., Ringdén, Olle, Schouten, Harry C, Seftel, Matthew, Rizzo, J. Douglas
Vydáno 2009

Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

Autor Soiffer, Robert J., LeRademacher, Jennifer, Ho, Vincent, Kan, Fangyu, Artz, Andrew, Champlin, Richard E., Devine, Steven, Isola, Luis, Lazarus, Hillard M., Marks, David I., Porter, David L., Waller, Edmund K., Horowitz, Mary M., Eapen, Mary
Vydáno 2011

DONOR CHARACTERISTICS AFFECTING GRAFT FAILURE, GRAFT vs. HOST DISEASE AND SURVIVAL AFTER UNRELATED DONOR TRANSPLANTATION WITH REDUCED INTENSITY CONDITIONING FOR HEMATOLOGIC MALIGNA...

Autor Passweg, Jakob R., Zhang, Mei-Jie, Rocha, Vanderson, Kan, Fangyu, Champlin, Richard E., Isola, Luis M., Gee, Adrian P., Gibson, John, Laughlin, Mary J., Lazarus, Hillard M., Loren, Alison, Marks, David I., Gratwohl, Alois, Eapen, Mary
Vydáno 2011

Delays in Post-Remission Chemotherapy for Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia are Associated with Inferior Outcomes in Patients who Undergo Allogeneic Tra...

Autor Kumar, Anita J., Gimotty, Phyllis A., Gelfand, Joel, Buck, Georgina, Rowe, Jacob M., Goldstone, Anthony H, Fielding, Adele, Marks, David I, Litzow, Mark, Paietta, Elisabeth, Lazarus, Hillard M., Tallman, Martin S., Luger, Selina M., Loren, Alison W.
Vydáno v Am J Hematol (2016)

Allogeneic Hematopoietic Cell Transplant for Prolymphocytic Leukemia

Autor Kalaycio, Matt E., Kukreja, Manisha, Woolfrey, Ann E., Szer, Jeffrey, Cortes, Jorge, Maziarz, Richard T., Bolwell, Brian J., Buser, Andreas, Copelan, Edward, Gale, Robert Peter, Gupta, Vikas, Maharaj, Dipnarine, Marks, David I, Pavletic, Steven Z., Horowitz, Mary M., Arora, Mukta
Vydáno 2009

UKALLXII/ECOG2993: addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia

Autor Fielding, Adele K., Rowe, Jacob M., Buck, Georgina, Foroni, Letizia, Gerrard, Gareth, Litzow, Mark R., Lazarus, Hillard, Luger, Selina M., Marks, David I., McMillan, Andrew K., Moorman, Anthony V., Patel, Bella, Paietta, Elisabeth, Tallman, Martin S., Goldstone, Anthony H.
Vydáno 2014

Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors

Autor Marks, David I., Woo, Kwang Ahn, Zhong, Xiaobo, Appelbaum, Frederick R., Bachanova, Veronika, Barker, Juliet N., Brunstein, Claudio G., Gibson, John, Kebriaei, Partow, Lazarus, Hillard M., Olsson, Richard, Perales, Miguel-Angel, Pidala, Joseph, Savani, Bipin, Rocha, Vanderson, Eapen, Mary
Vydáno 2014

Polymorphism in TGFB1 is associated with worse non-relapse mortality and overall survival after stem cell transplantation with unrelated donors

Autor Arrieta-Bolaños, Esteban, Mayor, Neema P., Marsh, Steven G.E., Madrigal, J. Alejandro, Apperley, Jane F., Kirkland, Keiren, Mackinnon, Stephen, Marks, David I., McQuaker, Grant, Perry, Julia, Potter, Michael N., Russell, Nigel H., Thomson, Kirsty, Shaw, Bronwen E.
Vydáno v Haematologica (2016)

Efficacy of inotuzumab ozogamicin in patients with Philadelphia chromosome–positive relapsed/refractory acute lymphoblastic leukemia

Autor Stock, Wendy, Martinelli, Giovanni, Stelljes, Matthias, DeAngelo, Daniel J., Gökbuget, Nicola, Advani, Anjali S., O’Brien, Susan, Liedtke, Michaela, Merchant, Akil A., Cassaday, Ryan D., Wang, Tao, Zhang, Hui, Vandendries, Erik, Jabbour, Elias, Marks, David I., Kantarjian, Hagop M.
Vydáno v Cancer (2020)